Study Information
| Title: | Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma  |
| Status: | Recruiting participants |
| Conditions: | Neuroblastoma |
| Interventions: | Drug: carboplatin; Drug: cyclophosphamide; Drug: etoposide; Drug: melphalan; Drug: thiotepa |
| Institutions: | Dana-Farber Cancer Institute, Massachusetts General Hospital, Tufts Medical Center |
| Health Topics: | Ewing's Sarcoma, Neuroblastoma |
Contact Information
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
Boston, MA 02115
Suzanne Shusterman
617-632-4901
Floating Hospital for Children at Tufts - New England Medical Center
Boston, MA 02111
Contact Person
617-636-5535
Massachusetts General Hospital
Boston, MA 02114
Clinical Trials Office - Massachusetts General Hospital
877-726-5130
UMASS Memorial Cancer Center - University Campus
Worcester, MA 01655
Christopher P. Keuker
508-856-4225